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Abstract
The ubiquitous Epstein–Barr virus (EBV) is related to the development of several lymphoid and epithelial malignancies and is also the
aetiological agent for infectious mononucleosis (IM). BZLF1, an immediate early gene, plays a key role in modulating the switch from latency
to lytic replication, hence enabling viral propagation. Polymorphic variations in the coded protein have been studied in other geographical
regions in a search for viral factors that are inherent to malignancies and differ from those present in benign infections. In the present study,
in samples of paediatric patients with benign IM and paediatric patients with malignant lymphomas, we detected previously described
sequence variations as well as distinctive sequence polymorphisms from our region. By means of phylogenetic reconstruction, we
characterized new phylogenetically distinct variants. Moreover, we described an association between speciﬁc variants and the studied
pathologies in our region, particularly variant BZLF1-A2 with lymphomas and BZLF1-C with IM. Additionally, length polymorphisms within
intron 1 were also assessed and compared between pathologies resulting in an association between 29-bp repeated units and lymphomas. In
conclusion, this is the ﬁrst report to characterize BZLF1 gene polymorphisms in paediatric patients from our geographical region and to
suggest the association of these polymorphisms with malignant lymphomas.
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Abstract
SFTS virus (SFTSV) is a novel bunyavirus that causes severe fever with thrombocytopenia syndrome (SFTS), an emerging infectious disease
that occurred in China in recent years, with an average case fatality rate of 10–12%. Intervention in the early clinical stage is the most
effective measure to reduce the mortality rate of disease. To elucidate the natural course of and immune mechanisms associated with the
pathogenesis of SFTSV, 59 laboratory-conﬁrmed SFTS patients in the acute phase, who were hospitalized between October 2010 and
September 2011, were enrolled in this study, and the patients sera were dynamically collected and tested for SFTSV viral RNA load, 34
cytokines or chemokines and other related laboratory parameters. All clinical diagnostic factors in the acute phase of SFTS were evaluated
and assessed. The study showed that the severity of the disease in 11 (18.6%) patients was associated with abdominal pain (p 0.007;
OR = 21.95; 95% CI, 2.32–208.11) and gingival bleeding (p 0.001; OR = 122.11; 95% CI, 6.41–2328). The IP-10, TNF-a, IL-6, IL-10,
granzyme B and HSP70 levels were higher over the 7–8 days in severe cases, accompanied by altered AST, CK and LDH levels. HSP70 (p
0.012; OR = 8.29; 95% CI, 1.58–43.40) was independently correlated with the severity of the early acute phase of SFTSV infection. The
severity of SFTS can be predicted based on the presence of symptoms such as abdominal pain and gingival bleeding and on the level of HSP70
in the acute phase of the disease.
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